clinical trial · NCT06842134
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
Parenteral NutritionNumeta G16%ESodium Glycerophosphate Injection
brief summary
This is a phase 1, prospective, single-center, randomized sequence, open label, 2-way crossover study comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E. It is planned to randomize approximately 16 healthy male and female subjects. All study periods will be completed during a single residency, the overall duration of residency will be 11 days (10 nights).
started
Jan 27, 2025
primary completion
May 22, 2025
completion
May 22, 2025
last updated
Jun 29, 2025
official title
Phase 1, Prospective, Single-Center, Randomized Sequence, Open Label, 2-Way Crossover Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol